<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Finch CL</submitter><funding>CCR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pubmed_abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing an exponentially increasing number of coronavirus disease 19 (COVID-19) cases globally. Prioritization of medical countermeasures for evaluation in randomized clinical trials is critically hindered by the lack of COVID-19 animal models that enable accurate, quantifiable, and reproducible measurement of COVID-19 pulmonary disease free from observer bias. We first used serial computed tomography (CT) to demonstrate that bilateral intrabronchial instillation of SARS-CoV-2 into crab-eating macaques (&lt;i>Macaca fascicularis&lt;/i>) results in mild-to-moderate lung abnormalities qualitatively characteristic of subclinical or mild-to-moderate COVID-19 (e.g., ground-glass opacities with or without reticulation, paving, or alveolar</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2020.05.14.096727</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7241101</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (&amp;lt;i&amp;gt;Macaca fascicularis&amp;lt;/i&amp;gt;).</pubmed_title><pmcid>PMC7241101</pmcid><funding_grant_id>T32 GM008692</funding_grant_id><funding_grant_id>F30 AI145182</funding_grant_id><funding_grant_id>HHSN261200800001E</funding_grant_id><funding_grant_id>HHSN261200800001C</funding_grant_id><funding_grant_id>HHSN272201800013C</funding_grant_id><pubmed_authors>Bartos C</pubmed_authors><pubmed_authors>Friedrich TC</pubmed_authors><pubmed_authors>Braun KM</pubmed_authors><pubmed_authors>Solomon J</pubmed_authors><pubmed_authors>Kuhn JH</pubmed_authors><pubmed_authors>Castro M</pubmed_authors><pubmed_authors>Larson PA</pubmed_authors><pubmed_authors>Kugelman JR</pubmed_authors><pubmed_authors>Feuerstein IM</pubmed_authors><pubmed_authors>Aiosa NM</pubmed_authors><pubmed_authors>Nason MC</pubmed_authors><pubmed_authors>Liang J</pubmed_authors><pubmed_authors>Kocher G</pubmed_authors><pubmed_authors>O'Connor DH</pubmed_authors><pubmed_authors>St Claire MC</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors><pubmed_authors>Finch CL</pubmed_authors><pubmed_authors>Burdette T</pubmed_authors><pubmed_authors>Di Paola N</pubmed_authors><pubmed_authors>Ramuta MD</pubmed_authors><pubmed_authors>Wada J</pubmed_authors><pubmed_authors>Crozier I</pubmed_authors><pubmed_authors>Kurtz JR</pubmed_authors><pubmed_authors>Sayre PJ</pubmed_authors><pubmed_authors>Adams R</pubmed_authors><pubmed_authors>Schmaljohn CS</pubmed_authors><pubmed_authors>Byrum R</pubmed_authors><pubmed_authors>Beitzel B</pubmed_authors><pubmed_authors>Johnson RF</pubmed_authors><pubmed_authors>Lackemeyer MG</pubmed_authors><pubmed_authors>Sharer K</pubmed_authors><pubmed_authors>Cooper TK</pubmed_authors><pubmed_authors>Palacios G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques (&amp;lt;i&amp;gt;Macaca fascicularis&amp;lt;/i&amp;gt;).</name><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing an exponentially increasing number of coronavirus disease 19 (COVID-19) cases globally. Prioritization of medical countermeasures for evaluation in randomized clinical trials is critically hindered by the lack of COVID-19 animal models that enable accurate, quantifiable, and reproducible measurement of COVID-19 pulmonary disease free from observer bias. We first used serial computed tomography (CT) to demonstrate that bilateral intrabronchial instillation of SARS-CoV-2 into crab-eating macaques (&lt;i>Macaca fascicularis&lt;/i>) results in mild-to-moderate lung abnormalities qualitatively characteristic of subclinical or mild-to-moderate COVID-19 (e.g., ground-glass opacities with or without reticulation, paving, or alveolar</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2026-05-19T03:11:44.23Z</modification><creation>2024-11-12T15:43:50.853Z</creation></dates><accession>S-EPMC7241101</accession><cross_references><pubmed>32511338</pubmed><doi>10.1101/2020.05.14.096727</doi></cross_references></HashMap>